DHG Stock Overview
Engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
DHG Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫103,100.00 |
| 52 Week High | ₫125,900.00 |
| 52 Week Low | ₫98,500.00 |
| Beta | 0.54 |
| 1 Month Change | 2.08% |
| 3 Month Change | -4.00% |
| 1 Year Change | -0.87% |
| 3 Year Change | -8.76% |
| 5 Year Change | 13.05% |
| Change since IPO | 150.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| DHG | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -7.2% | -3.0% | 0.9% |
| 1Y | -0.9% | 28.1% | 11.0% |
Return vs Industry: DHG underperformed the VN Pharmaceuticals industry which returned 29.6% over the past year.
Return vs Market: DHG underperformed the VN Market which returned 11.4% over the past year.
Price Volatility
| DHG volatility | |
|---|---|
| DHG Average Weekly Movement | 2.4% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in VN Market | 7.1% |
| 10% least volatile stocks in VN Market | 2.0% |
Stable Share Price: DHG has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: DHG's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | 2,796 | Toshiyuki Ishii | www.dhgpharma.com.vn |
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products primarily in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health supplements and pharmaceuticals cosmeceuticals.
DHG Pharmaceutical Joint Stock Company Fundamentals Summary
| DHG fundamental statistics | |
|---|---|
| Market cap | ₫13.48t |
| Earnings (TTM) | ₫804.09b |
| Revenue (TTM) | ₫4.96t |
16.8x
P/E Ratio2.7x
P/S RatioIs DHG overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DHG income statement (TTM) | |
|---|---|
| Revenue | ₫4.96t |
| Cost of Revenue | ₫2.84t |
| Gross Profit | ₫2.12t |
| Other Expenses | ₫1.32t |
| Earnings | ₫804.09b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.15k |
| Gross Margin | 42.82% |
| Net Profit Margin | 16.21% |
| Debt/Equity Ratio | 26.2% |
How did DHG perform over the long term?
See historical performance and comparisonDividends
7.3%
Current Dividend Yield122%
Payout RatioDoes DHG pay a reliable dividends?
See DHG dividend history and benchmarks| DHG Pharmaceutical dividend dates | |
|---|---|
| Ex Dividend Date | Dec 24 2024 |
| Dividend Pay Date | Feb 14 2025 |
| Days until Ex dividend | 7 days |
| Days until Dividend pay date | 45 days |
Does DHG pay a reliable dividends?
See DHG dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 05:03 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
DHG Pharmaceutical Joint Stock Company is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hang Thi Vu | CGS International |
| Kien Giang | FPT Securities |
| Michael Kokalari | Maybank Investment Bank Berhad |